2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
8
Breast
8
Lymphoid
4
Head & Neck
3
Gastrointestinal
3
Thoracic
2
Other
2
Classical hematology
2
Other hematologic neoplasm
1
Gynecologic
1
Dermatologic
1
CNS
1
Conditions
Melanoma
3139
Skin Neoplasms
554
Lymphoma, T-Cell, Cutaneous
543
Carcinoma, Non-Small-Cell Lung
421
Neoplasms
388
Mycosis Fungoides
369
Breast Neoplasms
364
Carcinoma, Basal Cell
359
Keratosis, Actinic
335
Sezary Syndrome
331
Lymphoma, Non-Hodgkin
312
Carcinoma, Renal Cell
308
Neoplasm Metastasis
304
Lymphoma
299
Leukemia, Lymphocytic, Chronic, B-Cell
292
Lymphoma, Large B-Cell, Diffuse
287
Lymphoma, Follicular
286
Hodgkin Disease
275
Uveal Melanoma
274
Lymphoma, B-Cell, Marginal Zone
273
Lymphoma, Mantle-Cell
272
Precursor Cell Lymphoblastic Leukemia-Lymphoma
271
Burkitt Lymphoma
258
Lymphoma, Large-Cell, Immunoblastic
248
Lung Neoplasms
236
Colorectal Neoplasms
232
Ovarian Neoplasms
214
Lymphoma, Large-Cell, Anaplastic
206
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
203
Multiple Myeloma
199
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Coronary Artery Disease
×
Dermatologic
×
Clear all
NCT04726319
2026-05-06
FHAMe
University of Toronto
Phase NA
Completed
627 enrolled